Navigation Links
ClinicalRM Awarded Omnibus III Contracts to Support the Navy Medical Research Center (NMRC)
Date:9/29/2011

HINCKLEY, Ohio, Sept. 29, 2011 /PRNewswire/ -- Clinical Research Management, (ClinicalRM) a full-service Contract Research Organization providing services for basic and applied research, clinical trials, and regulatory support, announced today it was awarded two contracts by the Navy Medical Research Center (NMRC) under its Omnibus III program. The awards are for the provision resources in support of NMRC, including: providing an infrastructure of personnel, materials, equipment, facilities, science, and technology that will sustain an acceptable level of medical research.  

ClinicalRM is one of only five other companies to be awarded contracts in both the Full & Open lot (W911QY-11-D-0051), which consists of 14 awardees, and the Small Business Set-Aside lot (W911QY-11-D-0065), which consists of 12 awardees. The contract ceiling for the 5 year Omnibus II program for all awardees is $497 M. The Omnibus III contract is an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract.  

The Omnibus III contract was issued with the intent of facilitating NMRC's mission to conduct R&D across its enterprise, including commands the Navy reports to or supports such as OASD-Health Affairs, JTF, CapMed, and more.  Other branches of the Government will be able to use the contract with approval of the Contracting Office.

"We have a history of providing similar basic and applied biomedical and clinical research expertise to other areas of the government and are extremely pleased to be part of this award to extend our support to the Navy.  Our company's priority is to improve the health and safety of our warfighters and their families through leading medical research," said Victoria Tifft, founder and CEO of ClinicalRM.  Said Tifft, "For 18 years we've proven ourselves as trusted and innovative partners to the U.S. Armed Forces research initiatives, and we look forward to extending that relationship within the Navy Medical Research Center."

Performance under the Omnibus III contract is expected to begin after the new fiscal year starts.  

About the Omnibus III Program

The Omnibus III requirement is to put in place personnel and process infrastructure that will facilitate Navy Medicine's mission to conduct Research & Development (R&D) across its enterprise, including commands that the Navy reports to or supports (e.g., OASD-Health Affairs, JTF CapMed, etc.). In addition to providing personnel, materials, equipment, and facilities (non-construction (bonded), non-Government spaces), this requirement addresses process infrastructure (such as basic university research, vaccine development, clinical trials, or FDA IND application processing).

Navy Medicine provides high quality, economical health care to beneficiaries in wartime and in peacetime. Highly trained Navy Medicine personnel deploy with Sailors and Marines worldwide – providing critical mission support aboard ship, in the air, and on the battlefield. At the same time, Navy Medicine's military and civilian health care professionals are providing care for uniformed services' family members and retirees at military treatment facilities around the globe.

About ClinicalRM

Founded in 1992, ClinicalRM is a full service Contract Research Organization (CRO) specializing in preclinical, and Phase I to Phase IV clinical research, clinical trial support, and product development for biologics, drugs, and devices. ClinicalRM prides itself on providing outstanding customer service and exceeding client expectations.  

ClinicalRM supports its clients with a wide array of regulatory and sponsor services including program and project management, site selection and management, recruitment, clinical data management, safety oversight, statistical analysis and reporting, training, and education within the U.S. and around the globe.  Our commercial, military, Federal and academic customers include: academic research institutions, NIH, Walter Reed Army Institute of Research, U.S. Army Medical Materiel Development Activity, U.S. Army Medical Research Institute of Infectious Diseases, and the Naval Medical Research Center. For more information, please go to: www.clinicalrm.com

Contact:
Dana Stanton
dstanton@clinicalrm.com
Ph: 800-431-9640   Fax: 800-538-1420
For General Information: info@clinicalrm.com


'/>"/>
SOURCE ClinicalRM
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ClinicalRM (formerly CRM) Awarded $97MM U.S. Army Contract to Support Military Clinical Research for the Warfighter
2. INRS professor Federico Rosei awarded Rutherford Memorial Medal for Chemistry
3. GeoVax Awarded $3.6 Million Grant by U.S. Government for its HIV/AIDS Vaccine Program
4. HumanTouch Awarded 8(a) STARS II GWAC Contract
5. Spatial Integrated Systems, Inc. Awarded Patent for 3D Imaging
6. Neuralstem Awarded Department of Defense Contract for Brain Cancer Research
7. Sofie Biosciences is Awarded a DOE Phase I SBIR to Commercialize Microscale Radiochemistry Platform
8. Medical College of Wisconsin and Cellular Dynamics Awarded NHLBI Grant Using Human Induced Pluripotent Stem Cells
9. Roche Building Awarded LEED® Gold Certification
10. Baylor College of Medicine and Texas Childrens Hospital Neuroscientist Dr. Huda Zoghbi Awarded Gruber Neuroscience Prize
11. 2011 Outstanding Young Scientist and Engineer Named; Baltimore City High School Students Awarded Glass Scholarships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... Most consumers ... with fingerprint recognition for secure access, voice recognition for hands-free communication, and facial ... are interacting with biometrics technology today. But if they asked Joey Pritikin, ...
(Date:4/27/2016)... ... April 27, 2016 , ... The Board of ... appointment of John Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from ... founding commercial leaders responsible for the commercialization of multiple orphan drug indications. ...
(Date:4/27/2016)... ... April 27, 2016 , ... A compact PET scanner ... and MRI (Magnetic Resonance Imaging) in existing third-party MRI systems. PET and MRI ... small animal subjects. Simultaneous PET/MRI imaging offers a solution to many challenges that ...
(Date:4/27/2016)... -- MedDay, a biotechnology company focused on the ... Catherine Moukheibir as Chairman of its Board of Directors. ... Garaud , who contributed to the rapid development of the ... Catherine started her career in strategy consulting and investment banking ... .  She held C-Suite level roles in some of ...
Breaking Biology Technology:
(Date:3/3/2016)... DE SOTO, Kansas , March 3, ... Plus® to offer Oncimmune,s Early CDT®-Lung, a blood ... detection of lung cancer Early CDT®-Lung test ... individuals. --> Early CDT®-Lung test to its ... --> Oncimmune, a leader in early cancer detection, ...
(Date:3/2/2016)... 2016 http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) ... "Global Biometrics as a Service Market 2016-2020" ... --> http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has announced the ... a Service Market 2016-2020" report to ... and Markets ( http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has announced ...
(Date:3/1/2016)... March 1, 2016  (RSAC Booth #3041) – True ... whopping $118 billion is lost to false positives, where ... inaccurate fraud detection. At the RSA Conference 2016, NuData ... companies handle authentication by devaluing the data fraudsters have ... --> --> ...
Breaking Biology News(10 mins):